|
|
Post by sweedee79 on Feb 26, 2016 19:36:41 GMT -5
Bless you Al Mann and family... Rest in peace.. You were an incredible amazing man, an inspiration for so many. Even though you didn't see Afrezza succeed... we are all here in support of this break through drug.... Matt and supporters will see this through one way or the other.. I am not selling.. I feel honored to have been a very small part of this and truly believe in the potential of Afrezza to help T1 and T2 diabetes patients world wide to achieve A1Cs they have never had before while at the same time leading happier more fulfilled lives... Your amazing vision is still possible....... thank you Al Mann... |
|
|
|
Post by BlueCat on Feb 26, 2016 19:53:08 GMT -5
I think he did see Afrezza succeed. Just not the stock price. But I think he knew it was coming.
|
|
|
|
Post by sportsrancho on Feb 26, 2016 21:33:16 GMT -5
Al died with out one doubt that Afrezza will be a blockbuster. He was not happy with SNY but they were just one more road block along the way. He stepped over road blocks and always looked forward. He very much trusts Matt to bring the ball home. From my friend: So sad to lose someone who has done so much for people. And so much for people with out them EVER knowing!
|
|
|
|
Post by lakers on Feb 27, 2016 2:52:33 GMT -5
Hope there will finally be a full 60min, 20/20 story about Al's contributions to Mankind, how he made a dent in the universe. Ironically, it may take his passing for Afrezza to finally be known nationally. As most of you I celebrate his meaningful life and great contribution to Mankind. May Al's spirit guide Matt and the BoD to realize his vision.
|
|
|
|
Post by mnkdfann on Feb 27, 2016 13:37:42 GMT -5
|
|
|
|
Post by irrationalexubera on Feb 27, 2016 14:02:24 GMT -5
sad that even the NYT gets the inhaler wrong, but in their (lazy) defense, that's the pic from their own NYT article on him in 2007; clearly they didn't bother researching the current delivery method of afrezza.
|
|
|
|
Post by ezrasfund on Feb 27, 2016 15:32:34 GMT -5
|
|
|
|
Post by mnholdem on Feb 29, 2016 9:38:22 GMT -5
I can truthfully say this about Al Mann:
He helped the blind see (Second Sight); and the deaf hear (Advanced Bionics cochlear implants); and the lame walk (Bioness and AMF are both developing systems to enable the lame to walk).
During his lifetime, Alfred E Mann brought light to those who lived in the shadow of death:
- Pacesetter Systems, Inc., which developed, manufactured and distributed cardiac pacemakers, from 1972 until 1985 when it was acquired by Siemens, AG. From 1985 to September 1992, Mr. Mann continued to serve as Chairman and CEO of the successor company, Siemens-Pacesetter, Inc., Pacesetter is now the Cardiac Rhythm Management unit of St. Jude Medical;
- MiniMed Inc (acquired by Medtronic, Inc. in August 2001) revolutionized diabetes treatment with its insulin pump;
- Mann founded and endowed, and from 1985 until 2006 served as Chairman of the Board of Trustees of The Alfred Mann Foundation, a nonprofit research organization devoted to development of advanced medical products in a variety of fields. Mr. Mann was Chairman of the Board of Trustees of the Alfred Mann Institutes at the University of Southern California and The Technion Institute (Israel), medical research foundations founded and endowed principally by Mr. Mann.
- MannKind Corporation, which develops novel therapeutics and drug delivery technologies for treatment primarily of diabetes, metabolic disease and cancer, whose lead product Afrezza which, according to early patient testimonials, is enabling diabetics to finally go to sleep at night without the fear of possibly never waking up.
---
Some point to individuals like Mother Teresa and other notables as models of what constitutes a life of devotion, dedicated to the service of others. I believe that Alfred E Mann fits somewhere within a lengthy list of men and women who spent their lives making the world a better place for all.
|
|
|
|
Post by factspls88 on Feb 29, 2016 9:56:31 GMT -5
The New York Times obituary is marred by sloppy journalism (wrong pic of inhaler) and by a quote from David Kliff who actively bashed Afrezza on Twitter and was a friend of Feuerstein. My question is, why didn't they interview one of the many Afrezza users who has had his/her life transformed by the drug? Why didn't they speak with Mannkind senior management? I used to have great respect for the mainstream newspapers and trusted them to have thoroughly researched their stories. Not any more. RIP Al.
|
|
|
|
Post by kball on Feb 29, 2016 10:02:22 GMT -5
I can truthfully say this about Al Mann:
He helped the blind see (Second Sight); and the deaf hear (Advanced Bionics cochlear implants); and the lame walk (Bioness and AMF are both developing systems to enable the lame to walk).
During his lifetime, Alfred E Mann brought light to those who lived in the shadow of death:
- Pacesetter Systems, Inc., which developed, manufactured and distributed cardiac pacemakers, from 1972 until 1985 when it was acquired by Siemens, AG. From 1985 to September 1992, Mr. Mann continued to serve as Chairman and CEO of the successor company, Siemens-Pacesetter, Inc., Pacesetter is now the Cardiac Rhythm Management unit of St. Jude Medical;
- MiniMed Inc (acquired by Medtronic, Inc. in August 2001) revolutionized diabetes treatment with its insulin pump;
- Mann founded and endowed, and from 1985 until 2006 served as Chairman of the Board of Trustees of The Alfred Mann Foundation, a nonprofit research organization devoted to development of advanced medical products in a variety of fields. Mr. Mann was Chairman of the Board of Trustees of the Alfred Mann Institutes at the University of Southern California and The Technion Institute (Israel), medical research foundations founded and endowed principally by Mr. Mann.
- MannKind Corporation, which develops novel therapeutics and drug delivery technologies for treatment primarily of diabetes, metabolic disease and cancer, whose lead product Afrezza which, according to early patient testimonials, is enabling diabetics to finally go to sleep at night without the fear of possibly never waking up.
---
Some point to individuals like Mother Teresa and other notables as models of what constitutes a life of devotion, dedicated to the service of others. I believe that Alfred E Mann fits somewhere within a lengthy list of men and women who spent their lives making the world a better place for all.
Said it before--The Edison of Medicine. |
|
|
|
Post by gamblerjag on Feb 29, 2016 11:07:36 GMT -5
Hey KC... all very true.. also sounds like the sequel to "Mary did you know", By Kenny Rogers/Judd.
|
|
|
|
Post by peppy on Mar 1, 2016 9:11:27 GMT -5
The Mannkind website homepage today.
|
|
|
|
Post by BlueCat on Mar 1, 2016 10:28:49 GMT -5
|
|
|
|
Post by mnkdfann on Mar 2, 2016 22:44:57 GMT -5
The New York Times obituary is marred by sloppy journalism (wrong pic of inhaler) and by a quote from David Kliff who actively bashed Afrezza on Twitter and was a friend of Feuerstein. Kliff said nothing but kind things about Al in the article, he gave effusive praise. For all we know, he may have supplied the highest praise from among those the writer contacted and the writer went with that. I think it is irrelevant who Kliff is, or who is friends are ... but if you consider him to be an 'enemy' of Al's in some sense, his praise is all the more impressive. As for the photo. Though I posted it above and was amused by it, I consider it no big deal. The article never said or suggested that the photo was of the latest and greatest version of the inhaler. Obituaries usually feature dated but historically significant photos. Al may well have been prouder of his first working model than the later, smaller refinement of it. When Steve Jobs died many obituaries featured photos of his early devices, not the latest and greatest. E.g.: www.wsj.com/articles/SB10001424052702304447804576410753210811910 (FWIW, I saw no complaints about the incredibly dated 2007 file photo of Al.) |
|
|
|
Post by compound26 on Mar 3, 2016 0:23:50 GMT -5
The New York Times obituary is marred by sloppy journalism (wrong pic of inhaler) and by a quote from David Kliff who actively bashed Afrezza on Twitter and was a friend of Feuerstein. Kliff said nothing but kind things about Al in the article, he gave effusive praise. For all we know, he may have supplied the highest praise from among those the writer contacted and the writer went with that. I think it is irrelevant who Kliff is, or who is friends are ... but if you consider him to be an 'enemy' of Al's in some sense, his praise is all the more impressive. As for the photo. Though I posted it above and was amused by it, I consider it no big deal. The article never said or suggested that the photo was of the latest and greatest version of the inhaler. Obituaries usually feature dated but historically significant photos. Al may well have been prouder of his first working model than the later, smaller refinement of it. When Steve Jobs died many obituaries featured photos of his early devices, not the latest and greatest. E.g.: www.wsj.com/articles/SB10001424052702304447804576410753210811910(FWIW, I saw no complaints about the incredibly dated 2007 file photo of Al.) I have no problem of NYT using an earlier version of Afrezza if NYT has clearly indicated that the picture was for an early version of Afrezza inhaler. In Job's case, we can easily tell that what was in the above picture was some old product Job worked on in his earlier years. And apple and iphone do not suffer from low awareness. In the case of Afrezza, given Afrezza suffers from low awareness painfully, people might misleadingly think what shown on the NYT article was the Afrezza inhaler that is being marketed right now. |
|
